David Aubuchon, M.B.A.

Vice President of Finance

Mr. Aubuchon brings over 25 years of finance and accounting experience to the company. Before joining Sigilon he was Vice President and Chief Accounting Officer at Aegerion Pharmaceuticals (now Novelion Therapeutics). Mr. Aubuchon’s career in the life science industry began at Sepracor (now Sunovion) where his most recent position was as SVP and Chief Accounting Officer. At Sepracor he spent over a decade managing all accounting and government pricing functions and helped the company grow from a research organization to a fully-fledged commercial pharmaceutical business with six approved products, including LUNESTA and XOPENEX. Mr. Aubuchon has also held senior financial positions with other life sciences companies, including Ocata Therapeutics and Inspiration Biopharmaceuticals.

Mr. Aubuchon started his accounting career at Coopers & Lybrand (now PricewaterhouseCoopers) and earned a CPA in the state of Massachusetts. He holds a B.A. from the University of Massachusetts at Amherst and an M.B.A. from Babson College.

‹ Back